Analysis of early viral kinetics in chronic hepatitis C genotype 2 or 3 patients treated with peginterferon Alpha-2a and ribavirin

被引：0
|
作者：
Scherzer, Thomas-Matthias
Staufer, Katharina
Steindl-Munda, Petra
Holzmann, Heidemarie
Ferenci, Peter
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A789 / A789
页数：1
相关论文
共 50 条
  • [21] Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C
    Hauser, Goran
    Awad, Tahany
    Thorlund, Kristian
    Stimac, Davor
    Mabrouk, Mahasen
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):
  • [22] Cytokine signature in chronic hepatitis C patients treated with peginterferon alpha 2A and ribavirin
    Neuman, M. G.
    Malkiewicz, I. M.
    Esguerra, R.
    Sha, K.
    Mazulli, T.
    Moussa, G.
    Morgan, M.
    Cohen, L.
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 198 - 198
  • [23] HIGHLY EFFECTIVE PEGINTERFERON ALPHA-2A PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C IN PATIENTS WITH HEMOPHILIA
    Lee, Hyun Woong
    Kim, Hyung J.
    Lee, Youn-Jae
    Park, Sung Jae
    Baek, Eun Kyung
    Kim, Ki-Seong
    Cha, Bong Ki
    Lee, Seung-Yong
    Oh, Hyoung-Chul
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Jae Hyuk
    Kim, Jae G.
    Chang, Sae Kyung
    HEPATOLOGY, 2009, 50 (04) : 1020A - 1020A
  • [24] Efficacy and Safety of Peginterferon alpha-2a/Ribavirin in Treatment-Naive Cameroonian Patients With Chronic Hepatitis C
    Njouom, Richard
    Sartre, Michele Tagni
    Timba, Isabelle
    Nerrienet, Eric
    Tchendjou, Patrice
    Pasquier, Christophe
    Rousset, Dominique
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (12) : 2079 - 2085
  • [25] Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Treatment in Chronic Hepatitis C Patients Depends on Various Baseline Parameters and Early Viral Kinetics
    Husa, P.
    Slesinger, P.
    Stroblova, H.
    Svobodnik, A.
    Husova, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E420 - E421
  • [26] VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN
    Loaeza del Castillo, Aurora
    Sixtos-Alonso, S.
    Sanchez-Avila, F.
    Uribe, M.
    HEPATOLOGY, 2009, 50 (04) : 965A - 965A
  • [27] Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians
    Cooper, Curtis L.
    Bailey, Robert J.
    Bain, Vince C.
    Anderson, Frank
    Yoshida, Eric M.
    Krajden, Mel
    Marotta, Paul
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 22 (08) : 677 - 680
  • [28] Plasma ribavirin quantification in patients with chronic hepatitis C, genotype 1, treated with Peginterferon and ribavirin
    Muñoz de Rueda, Paloma
    Rodriguez, Luis
    Caudel, Jose Manuel
    Quiles, Rosa
    Andrade, Raúl
    Diago, Moises
    Navarro, Jose Maria
    HEPATOLOGY, 2006, 44 (04) : 340A - 340A
  • [29] Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
    Pouresmaeeli, Mahdiyar
    Alavian, Seyed Moayed
    Keshvari, Maryam
    Salimi, Shima
    Mehrnoush, Leila
    HEPATITIS MONTHLY, 2015, 15 (09)
  • [30] Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis C: a randomized, controlled study
    Bruno, R
    Sacchi, P
    Ciappina, V
    Zochetti, C
    Patruno, S
    Maiocchi, L
    Filice, G
    ANTIVIRAL THERAPY, 2004, 9 (04) : 491 - 497
12345